Skip to main content
Benaroya Research Institute

Main navigation

  • About BRI
    • Leadership
    • Faculty
    • Administrative Leaders
    • Together We Discover
    • Contact Us
  • Our Research
    • Centers of Discovery
      • Fundamental Immunology
      • Translational Immunology
      • Interventional Immunology
      • Systems Immunology
        • Bioinformatics at BRI
    • Labs
    • Biorepositories
      • Be a Part of BRI Research
    • Clinical Research
      • Allergies & Asthma Clinical Research
    • Core Labs
      • Cell And Tissue Analysis Group
      • Genomics Core
      • Human Immunophenotyping Core
      • Protein and Tetramer Core
        • Protein & Tetramer Core Ordering
    • Immune Tolerance Network
    • Scientific Publications
    • Scientific Meetings at BRI
      • Asthma Research Symposium
      • BRI Immunology Symposium: New Horizons in Immunity and Disease
      • Cross Autoimmunity Prevention Symposium
  • Collaborations with BRI
    • Opportunities for Collaboration
    • Technology Available for Licensing
  • News
    • Press Releases
  • Support our Research
    • Donate Now
    • BRI Events
      • BRI Open House
      • Immunology to Change Lives

Utility Menu

  • Immunology Learning Center
  • Autoimmune Life Blog
  • Careers
  • Clinical Research at VMMC
  • Donate
  • Search
    • Mar 2025

      Single cell profiling of circulating autoreactive CD4 T cells from patients with autoimmune liver diseases suggests tissue imprinting.

      Nat Commun
      Cardon A, Guinebretière T, Dong C, Gil L, Ado S, Gavlovsky PJ, Braud M, Danger R, Schultheiß C, Doméné A, Paul-Gilloteaux P, Chevalier C, Bernier L, Judor JP, Fourgeux C, Imbert A, Khaldi M, Bardou-Jacquet E, Elkrief L, Lannes A, Silvain C, Schnee M, Tanne F, Vavasseur F, Brusselle L, Brouard S, Kwok WW, Mosnier JF, Lohse AW, Poschmann J, Binder M, Gournay J, Conchon S, Milpied P, Renand A
    • Nov 2024

      Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritis.

      RMD Open
      Turcinov S, Sharma RK, De Vries C, Cîrciumaru A, Gerstner C, Mathsson-Alm L, Raposo B, Dubnovitsky A, Rönnblom L, Kwok WW, Chemin K, Malmström V, Hensvold A
    • Nov 2024

      Antigen-specific T-cell frequency and phenotype mirrors disease activity in DRB1*04:04+ rheumatoid arthritis patients.

      Clin Exp Immunol
      Rims C, Uchtenhagen H, Brooks K, Ng B, Posso SE, Carlin J, Kwok WW, Buckner JH, James EA
    • Oct 2024

      Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers.

      Diabetologia
      Zhao LP, Papadopoulos GK, Skyler JS, Pugliese A, Parikh HM, Kwok WW, Lybrand TP, Bondinas GP, Moustakas AK, Wang R, Pyo CW, Nelson WC, Geraghty DE, Lernmark A
    • Jul 2024

      Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07).

      Diabetes Care
      Zhao LP, Papadopoulos GK, Skyler JS, Parikh HM, Kwok WW, Bondinas GP, Moustakas AK, Wang R, Pyo CW, Nelson WC, Geraghty DE, Lernmark A
    • May 2024

      T-cell receptor sequencing in interrogating antigen-specific T-cell responses to foreign and self-antigens.

      J Allergy Clin Immunol
      Johansson AM, Kwok WW
    • Mar 2024

      HLA Class II (DR, DQ, DP) Genes Were Separately Associated With the Progression From Seroconversion to Onset of Type 1 Diabetes Among Participants in Two Diabetes Prevention Trials (DPT-1 and TN07).

      Diabetes Care
      Zhao LP, Papadopoulos GK, Skyler JS, Pugliese A, Parikh HM, Kwok WW, Lybrand TP, Bondinas GP, Moustakas AK, Wang R, Pyo CW, Nelson WC, Geraghty DE, Lernmark A
    • Jul 2023

      Technical Validation and Utility of an HLA Class II Tetramer Assay for Type 1 Diabetes: A Multicenter Study.

      J Clin Endocrinol Metab
      Ettinger RA, Buitinga M, Vandamme C, Afonso G, Gomez R, Arribas-Layton D, Bissenova S, Speake C, Reijonen H, Kinnunen T, Overbergh L, Mallone R, Kwok WW, James EA
    • May 2023

      Evidence for broad cross-reactivity of the SARS-CoV-2 NSP12-directed CD4(+) T-cell response with pre-primed responses directed against common cold coronaviruses.

      Front Immunol
      Westphal T, Mader M, Karsten H, Cords L, Knapp M, Schulte S, Hermanussen L, Peine S, Ditt V, Grifoni A, Addo MM, Huber S, Sette A, Lütgehetmann M, Pischke S, Kwok WW, Sidney J, Schulze Zur Wiesch J
    • Mar 2023

      Distinct trajectories distinguish Antigen-specific T cells in peanut-allergic individuals undergoing oral immunotherapy.

      J Allergy Clin Immunol
      Calise J, DeBerg H, Garabatos N, Khosa S, Bajzik V, Calderon LB, Aldridge K, Rosasco M, Ferslew BC, Zhu T, Smulders R, Wheatley LM, Laidlaw TM, Qin T, Chichili GR, Adelman DC, Farrington M, Robinson D, Jeong D, Jones SM, Sanda S, Larson D, Kwok WW, Baloh C, Nepom GT, Wambre E
    • Jan 2023

      Characterizing T cell responses to enzymatically modified beta cell neo-epitopes.

      Front Immunol
      Nguyen H, Arribas-Layton D, Chow IT, Speake C, Kwok WW, Hessner MJ, Greenbaum CJ, James EA
    • Oct 2022

      HLA-DR3 restricted environmental epitopes from the bacterium Clostridium tetani have T cell cross-reactivity to the SLE-related autoantigen SmD.

      Front Immunol
      Zhao Z, Anderson AN, Kannapell CC, Kwok WW, Gaskin F, Fu SM
    • Aug 2022

      A gut microbial peptide and molecular mimicry in the pathogenesis of type 1 diabetes.

      Proc Natl Acad Sci U S A
      Girdhar K, Huang Q, Chow IT, Vatanen T, Brady C, Raisingani A, Autissier P, Atkinson MA, Kwok WW, Kahn CR, Altindis E
    • Jun 2022

      High and Sustained Ex Vivo Frequency but Altered Phenotype of SARS-CoV-2-Specific CD4+ T-Cells in an Anti-CD20-Treated Patient with Prolonged COVID-19.

      Viruses
      Cords L, Knapp M, Woost R, Schulte S, Kummer S, Ackermann C, Beisel C, Peine S, Johansson AM, Kwok WW, Günther T, Fischer N, Wittner M, Addo MM, Huber S, Schulze Zur Wiesch J
    • Jun 2022

      Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease Activity.

      J Am Soc Nephrol
      Chen D, McInnis E, Wu E, Stember K, Hogan S, Hu Y, Henderson C, Blazek L, Mallal S, Karosiene E, Peters B, Sidney J, James EA, Kwok WW, Jennette JC, Ciavatta DJ, Falk RJ, Free ME

Pagination

Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 … Next page Next › Last page Last »
Benaroya Research Institute

1201 Ninth Avenue
Seattle, WA 98101-2795
(206) 342-6500

facebook Bluesky instagram linkedin youtube threads
Resources
  • Support our Research
  • Subscribe to News
  • Careers
  • Contact Us
  • Research Conflicts of Interest
  • Research Security Program
  • Terms of Use
  • Research Requirements
If you would like to contact us regarding the accessibility of our website, please contact us at 206-342-6500 or email communications@benaroyaresearch.org.
© 2025 Benaroya Research Institute, a 501(c)(3) nonprofit organization
Close Close